Skip to content
WeighLab
Menu
Ranked #191 · Grade C

Lttl review

Lttl (pronounced 'little') is a direct-to-consumer telehealth brand offering compounded semaglutide and tirzepatide, a low-dose 'microdose' line, and longevity peptides.

Visit Lttl Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (all doses, compounded)
Tirzepatide
$279/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$3,348

The Index scorecard

Lttl scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month65/100
Price Transparency94/100
Nationwide Access24/100
Formulation Options90/100
Clinical Oversight76/100
Contract Flexibility20/100

Where the value is

  • Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
  • Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
  • States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
  • Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
  • Oral ODT semaglutide offered for members who want to avoid injections

The tradeoffs

  • Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
  • The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
  • No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
  • Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
  • Medications cannot be returned or refunded once they ship from the pharmacy

The bottom line

Best for: Shoppers who want every commitment tier priced openly, plus a low-dose microdose option. Lttl (pronounced 'little') is a direct-to-consumer telehealth brand offering compounded semaglutide and tirzepatide, a low-dose 'microdose' line, and longevity peptides.

Ranked #191 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Lttl.

The 18 programs nearest this one

Pricing, states and verification reflect Lttl's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Lttl's site. Not medical advice; see our disclosure.

← Back to the value leaderboard